GridAI Technologies (GRDX) Other Non Operating Income (2020 - 2025)
GridAI Technologies' (GRDX) quarterly Other Non Operating Income came in at $1.0 million in Q4 2025, up 11192.36% YoY from N/an in Q4 2024, and up 104307600.0% on a QoQ basis from -$1.0 in Q2 2025.
GridAI Technologies (GRDX) Other Non Operating Income (2020 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 6 years of Other Non Operating Income data on file, last reported at $1.0 million in Q4 2025.
- Quarterly Other Non Operating Income rose 11192.36% year-over-year to $1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $934257.0 (up 67698.04% YoY) and the FY2025 annual result came in at $934257.0, up 67698.04% from the prior year.
- Other Non Operating Income rose to $1.0 million in Q4 2025, from -$1.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $1.0 million in Q4 2025 to a low of -$239301.0 in Q1 2022.
- A 5-year average of $76710.6 and a median of -$610.5 in 2021 frame the typical range for Other Non Operating Income.
- The widest YoY moves for Other Non Operating Income: up 11192.36% in 2025, down 16564.17% in 2025.
- Tracing GRDX's Other Non Operating Income over 5 years: stood at -$4284.0 in 2021, then soared by 253.13% to $6560.0 in 2022, then slumped by 107.55% to -$495.0 in 2023, then soared by 1966.06% to $9237.0 in 2024, then surged by 11192.36% to $1.0 million in 2025.
- The last three Other Non Operating Income figures came in at $1.0 million (Q4 2025), -$1.0 (Q2 2025), and -$108817.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | GridAI Technologies | 5.82 Mn | 5.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.04 Mn |
| Jun 30, 2025 | -1.00 |
| Mar 31, 2025 | -108,817.00 |
| Dec 31, 2024 | 9,237.00 |
| Sep 30, 2024 | -2,874.00 |
| Jun 30, 2024 | -4,332.00 |
| Mar 31, 2024 | -653.00 |
| Dec 31, 2023 | -495.00 |
| Jun 30, 2023 | -2,615.00 |
| Mar 31, 2023 | -1,114.00 |
| Dec 31, 2022 | 6,560.00 |
| Mar 31, 2022 | -239,301.00 |
| Dec 31, 2021 | -4,284.00 |
| Sep 30, 2021 | -568.00 |
| Jun 30, 2021 | 898.00 |
| Mar 31, 2021 | 532,653.00 |
| Dec 31, 2020 | -609,998.00 |